Skip to main content

M MC2 Pill - orange capsule/oblong, 17mm

Pill with imprint M MC2 is Orange, Capsule/Oblong and has been identified as Mycophenolic Acid Delayed-Release 360 mg. It is supplied by Mylan Pharmaceuticals Inc.

Mycophenolic acid is used in the treatment of Rejection Prophylaxis and belongs to the drug class selective immunosuppressants. There is positive evidence of human fetal risk during pregnancy. Mycophenolic acid 360 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for M MC2

Mycophenolic acid delayed-release 360 mg M MC2

Mycophenolic Acid Delayed-Release

360 mg
17.00 mm
Prescription only
Drug Class
Selective immunosuppressants
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Mylan Pharmaceuticals Inc.
Inactive Ingredients
silicon dioxide, croscarmellose sodium, FD&C Blue No. 2, hypromelloses, hypromellose acetate succinate 12070923 (3 mm2/s), magnesium stearate, maltodextrin, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, corn starch, propylene glycol, sodium lauryl sulfate, magnesium silicate, titanium dioxide, triethyl citrate, ferrosoferric oxide, FD&C Red No. 40, FD&C Yellow No. 6, ammonia, shellac

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00378-4202 Mylan Pharmaceuticals Inc.
51079-0509 UDL Laboratories Inc.

Get help with Imprint Code FAQs.

Related images for "M MC2"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.